Respiratory
-
Long COVID clinics promised
England is to have a network of long COVID clinics aimed at identifying and providing treatment for the syndrome, it has been announced. Read more
-
Long COVID guideline to be developed
A guideline on the persistent effects of COVID-19, known as Long COVID, is to be developed by NICE, the Scottish Intercollegiate Guidelines Network (SIGN), and the Royal College of General Practitioners (RCGP). Read more
-
One fifth of COVID cases likely asymptomatic
About a fifth of people infected with COVID-19 are asymptomatic – although the proportion may be greater among health workers, according to new studies. Read more
-
Social smokers face disproportionate lung disease and cancer risk
So-called “social smokers” are more than twice as likely to die of lung disease and more than eight times as likely to die from lung cancer than non-smokers, a European conference hears today. Read more
-
COVID-19 social distancing advice may be mistaken
The one or two metre physical distancing measures used as guidance during the COVID-19 pandemic are based on inaccurate science, it was claimed today. Read more
-
Evidence for honey improving cough
Honey is more effective than the usual treatments for upper respiratory tract infections, according to a new analysis supporting the use of one of the world’s most ancient remedies for coughs and colds. Read more
-
Smell and taste loss in COVID-19 explained
Scientists have announced new insights into how COVID-19 infection can cause loss of taste and smell. Read more
-
Sweden’s relaxed lockdown failed to achieve herd immunity
Sweden, among European countries, took a deliberately relaxed approach to the COVID-19 lockdown – but this has failed to deliver herd immunity, according to an analysis published today. Read more
-
Different treatment needed for non-smoking lung cancer patients
Lung cancer in non-smokers is a different disease from that found in smokers and is likely to require different treatment, a new study published last night has found. Read more
-
Could an anaemia drug help COVID-19 patients?
Scientists are investigating whether a common anaemia drug, erythropoietin, could become an effective treatment for COVID-19. Read more